Meeting
2015 ASCO Annual Meeting
Phase I study of preoperative chemoradiation with temozolomide and capecitabine in patients with locally advanced rectal cancer.
Authors
Yong Sang Hong
Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
Yong Sang Hong , Seong Joon Park , Jeong Eun Kim , Kyu-Pyo Kim , Jae-Lyun Lee , Jin-hong Park , Jong Hoon Kim , Chang Sik Yu , Jin Cheon Kim , Tae Won Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Clinical Trial Registration Number
NCT01781403
Citation
J Clin Oncol 33, 2015 (suppl; abstr 3569)
DOI
10.1200/jco.2015.33.15_suppl.3569
Abstract #
3569
Poster Bd #
61
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Preoperative chemoradiotherapy with capecitabine with or without temozolomide in patients with locally advanced rectal cancer: A prospective, randomized phase 2 study stratified by MGMT (O6-methylguanine DNA methyltransferase) status: KCSG-CO17-02.
First Author: Chung Ryul Oh
Poster
2020 ASCO Virtual Scientific Program
Short-term results of VOLTAGE-A: Nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stable and microsatellite instability-high locally advanced rectal cancer.
First Author: Satoshi Yuki
Poster
2019 ASCO Annual Meeting
Voltage: Investigator-initiated clinical trial of nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stable locally advanced rectal cancer.
First Author: Takayuki Yoshino
Poster
2018 Gastrointestinal Cancers Symposium
VOLTAGE: Multicenter phase 1b/II study of nivolumab monotherapy and subsequent radical surgery after preoperative chemoradiotherapy with capecitabine in patients with locally advanced rectal cancer.
First Author: Yuichiro Tsukada